Mindeudesivir (hydrobromide)
Mindeudesivir (JT001; VV116; GS-621763-d1) hydrobromide is a deuterated version of Remdesivir , a highly orally active nucleoside antiviral against SARS-CoV-2 and respiratory syncytial virus (RSV). Mindeudesivir hydrobromide retains the antiviral activity of Remdesivir against COVID-19, and is the first domestically produced deuterium targeting the COVID-19[1][2].
Product Specifications
CAS Number
2779498-79-0
Product Name Alternative
VV116; GS-621763-d1 (hydrobromide)
UNSPSC
12352005
Target
Influenza Virus; RSV; SARS-CoV
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Purity
98.16
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
[H]Br.N#C[C@](O[C@@H]1COC(C(C)C)=O)(C2=CC([2H])=C3N2N=CN=C3N)[C@@H]([C@@H]1OC(C(C)C)=O)OC(C(C)C)=O
Molecular Formula
C24H31DBrN5O7
Molecular Weight
583.45
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Beta-Nicotinamide Adenine Dinucleotide Phosphate Sodium Salt Hydrate (~90%)
PAX8 (Renal Cell Marker) (PAX8/1491 + PAX8/1492), CF568 conjugate, 0.1mg/mL
